Showing results (51-60 of 218) with videos related to
Sort By:
Pageof 22
Cancer Research|January 8, 2017
Mutated Chromatin Regulatory Factors as Tumor Drivers in CancerCarl Koschmann, Felipe J Nunez, Flor Mendez, et al.Current Topics in Medicinal Chemistry|October 27, 2005
Combining cytotoxic and immune-mediated gene therapy to treat brain tumorsJames F Curtin, Gwendalyn D King, Marianela Candolfi, et al.Cancer Research|July 20, 2014
Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunityGregory J Baker, Peter Chockley, Viveka Nand Yadav, et al.Human Gene Therapy. Clinical Development|September 7, 2013
Effectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a phase I clinical trial for gliomaNathan VanderVeen, Christopher Paran, Jonathan Krasinkiewicz, et al.Nature Communications|November 11, 2020
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapyJason V Gregory, Padma Kadiyala, Robert Doherty, et al.Circulation|November 26, 2003
Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplastyPaul A Kingston, Sanjay Sinha, Clare E Appleby, et al.Neuron Glia Biology|December 18, 2007
Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cellsCarlos Barcia, Christian Gerdes, Wei-Dong Xiong, et al.Frontiers in Oncology|October 24, 2022
The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implicationsSyed M Faisal, Andrea Comba, Maria L Varela, et al.Expert Opinion on Biological Therapy|March 14, 2017
Single vs. combination immunotherapeutic strategies for gliomaMayuri Chandran, Marianela Candolfi, Diana Shah, et al.Oncoimmunology|February 6, 2018
Melanoma induced immunosuppression is mediated by hematopoietic dysregulationNeha Kamran, Youping Li, Maria Sierra, et al.Pageof 22